Publication date: April 2019Source: Annals of Allergy, Asthma & Immunology, Volume 122, Issue 4Author(s): Gailen D. Marshall
Thu Apr 04, 2019 14:30
Publication date: April 2019Source: Annals of Allergy, Asthma & Immunology, Volume 122, Issue 4Author(s):
Thu Apr 04, 2019 14:30
Publication date: April 2019Source: Annals of Allergy, Asthma & Immunology, Volume 122, Issue 4Author(s):
Thu Apr 04, 2019 14:30
Publication date: April 2019Source: Annals of Allergy, Asthma & Immunology, Volume 122, Issue 4Author(s):
Thu Apr 04, 2019 14:30
Publication date: April 2019Source: Annals of Allergy, Asthma & Immunology, Volume 122, Issue 4Author(s):
Thu Apr 04, 2019 14:30
Publication date: April 2019Source: Annals of Allergy, Asthma & Immunology, Volume 122, Issue 4Author(s): Tatjana Welzel, Victoria C. Ziesenitz, Stefanie Seitz, Birgit Donner, Johannes N. van den Anker
Thu Apr 04, 2019 14:30
Publication date: April 2019Source: Annals of Allergy, Asthma & Immunology, Volume 122, Issue 4Author(s): John R. Cohn
Thu Apr 04, 2019 14:30
We previously reported that racial differences in rates of allergic disease outcomes emerge as early as age 2 years, but could not explain the differences by examining a series of individual factors.(1, 2) Hypothesizing that racial differences are not entirely due to genetic factors, this challenge called for the application of an analytical approach that would simultaneously address the interrelatedness of the factors given power constraints. Latent class (LC) analysis uses underlying relationships...
Thu Apr 04, 2019 03:00
The type 2 high endotype of asthma with adult onset is often characterized by severe persistent, steroid refractory eosinophilic inflammation. Interleukin-5 (IL-5) is a pivotal cytokine for eosinophil survival. The amelioration of eosinophilic inflammation through anti-IL-5 therapies (mepolizumab, reslizumab, and benralizumab) has been demonstrated to reduce exacerbations and improve control, and overall well-tolerated.
Thu Apr 04, 2019 03:00
AbstractBackgroundSeveral studies demonstrated the adverse effect of milk processing on the allergy‐protective capacity of raw cow's milk. Whether milk processing also affects the allergenicity of raw milk is hardly investigated.ObjectiveTo assess the allergenicity of raw (unprocessed) and processed cow's milk in a murine model for food allergy as well as in cow's milk allergic children.MethodsC3H/HeOuJ mice were either sensitized to whole milk (raw cow's milk, heated raw cow's milk or...
Wed Apr 03, 2019 17:28
Following publication of the original article [1], the authors reported that one of the authors' name was spelled incorrectly.
Thu Apr 04, 2019 03:00
Skin is replete with immune-competent cells that modulate signaling pathways to maintain a salubrious immunogenic/tolerogenic balance. This fertile immune environment plays a significant role in the development of allergic responses and sensitivities, but the mechanisms underlying these pathways have been underappreciated and underutilized with respect to developing therapeutics. Among the complex repertoire of cells that promote tolerogenic pathways in the periphery, two key classes include dendritic...
Thu Apr 04, 2019 03:00
Publication date: April 2019Source: Journal of Allergy and Clinical Immunology, Volume 143, Issue 4Author(s):
Thu Apr 04, 2019 15:50
Publication date: April 2019Source: Journal of Allergy and Clinical Immunology, Volume 143, Issue 4Author(s):
Thu Apr 04, 2019 15:50
Publication date: April 2019Source: Journal of Allergy and Clinical Immunology, Volume 143, Issue 4Author(s):
Thu Apr 04, 2019 15:50
Publication date: April 2019Source: Journal of Allergy and Clinical Immunology, Volume 143, Issue 4Author(s):
Thu Apr 04, 2019 15:50
Publication date: April 2019Source: Journal of Allergy and Clinical Immunology, Volume 143, Issue 4Author(s): Marc E. Rothenberg, Jean Bousquet
Thu Apr 04, 2019 15:50
Publication date: April 2019Source: Journal of Allergy and Clinical Immunology, Volume 143, Issue 4Author(s): Zuhair K. Ballas, Associate Editors of the JACI
Thu Apr 04, 2019 15:50
Publication date: April 2019Source: Journal of Allergy and Clinical Immunology, Volume 143, Issue 4Author(s):
Thu Apr 04, 2019 15:50
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου
Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182,00306932607174,alsfakia@gmail.com,